Experimental models of multiple sclerosis

被引:63
|
作者
Pachner, Andrew R. [1 ]
机构
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ 07103 USA
关键词
animal models; autoimmunity; demyelination; multiple sclerosis; virus; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; THEILERS-VIRUS-INFECTION; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; B-CELL DEPLETION; DEMYELINATING DISEASE; NEUROMYELITIS-OPTICA; VIRAL REPLICATION; IMMUNE-RESPONSES;
D O I
10.1097/WCO.0b013e328346c226
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose of review Multiple sclerosis (MS) is a disease of the central nervous system of unknown cause. There are many medications available for the disease, but none are clearly effective in ameliorating its long-term disabling effects. MS is felt to be most likely either due to an aberrant immune response or a pathogen, or possibly a combination of the two, and the animal models available reflect these two possible pathogeneses. The hallmarks of the disease are demyelination, inflammation, axonal injury, and progressive disability. This review explores the experimental models of multiple sclerosis. Recent findings There are a variety of forms of experimental allergic encephalomyelitis, the most commonly studied animal model of MS. Two viruses, Theiler's murine encephalomyelitis virus and murine hepatitis virus, are used to induce infectious models of the disease. Summary The animal models have their advantages and disadvantages, but no model fully reproduces the spectrum of the human disease.
引用
收藏
页码:291 / 299
页数:9
相关论文
共 50 条
  • [31] Fc multimers effectively treat murine models of multiple sclerosis
    Wang, Jin
    Brown, Kellie
    Danehy, Caroline
    Merigeon, Emmanuel
    Goralski, Stephen
    Rice, Samuel
    Torgbe, Kwame
    Thomas, Fridtjof
    Block, David
    Olsen, Henrik
    Strome, Scott E.
    Fitzpatrick, Elizabeth A.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [32] Pathogenic CD8T cells in multiple sclerosis and its experimental models
    Huseby, Eric S.
    Huseby, Priya G.
    Shah, Shivanee
    Smith, Rebecca
    Stadinski, Brian D.
    FRONTIERS IN IMMUNOLOGY, 2012, 3
  • [33] Experimental in vivo and in vitro models of multiple sclerosis: EAE and beyond
    Kipp, Markus
    van der Star, Baukje
    Vogel, Daphne Y. S.
    Puentes, Fabiola
    van der Valk, Paul
    Baker, David
    Amor, Sandra
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2012, 1 (01) : 15 - 28
  • [34] The genetics of multiple sclerosis and its experimental models
    Olsson, Tomas
    Hillert, Jan
    CURRENT OPINION IN NEUROLOGY, 2008, 21 (03) : 255 - 260
  • [35] CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis - Targeting T or B cells?
    Agahozo, Marie Colombe
    Peferoen, Laura
    Baker, David
    Amor, Sandra
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 9 : 110 - 117
  • [36] Influence of Peripheral inflammation on the progression of multiple sclerosis: Evidence from the clinic and experimental animal models
    Murta, Veronica
    Ferrari, Carina C.
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2013, 53 : 6 - 13
  • [37] Remyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration
    Packer, Davin
    Fresenko, Emily. E. E.
    Harrington, Em. P. P.
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2023, 16
  • [38] Monoclonal Antibodies in Preclinical EAE Models of Multiple Sclerosis: A Systematic Review
    Schmitz, Katja
    Geisslinger, Gerd
    Tegeder, Irmgard
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (09):
  • [39] The Translatability of Multiple Sclerosis Animal Models for Biomarkers Discovery and Their Clinical Use
    Birmpili, Dafni
    Askar, Imane Charmarke
    Bigaut, Kevin
    Bagnard, Dominique
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [40] Experimental allergic encephalomyelitis animal models for analyzing features of multiple sclerosis
    Petry, KG
    Boullerne, AI
    Pousset, F
    Brochet, B
    Caillé, JM
    Dousset, V
    PATHOLOGIE BIOLOGIE, 2000, 48 (01): : 47 - 53